AR099692A1 - Derivados cristalinos de (s)-1-((2r,3r,4s,5s)-5-alil-3-metoxi-4-(tosilmetil)tetrahidrofuran-2-il)-3-aminopropan-2-ol - Google Patents
Derivados cristalinos de (s)-1-((2r,3r,4s,5s)-5-alil-3-metoxi-4-(tosilmetil)tetrahidrofuran-2-il)-3-aminopropan-2-olInfo
- Publication number
- AR099692A1 AR099692A1 ARP150100686A ARP150100686A AR099692A1 AR 099692 A1 AR099692 A1 AR 099692A1 AR P150100686 A ARP150100686 A AR P150100686A AR P150100686 A ARP150100686 A AR P150100686A AR 099692 A1 AR099692 A1 AR 099692A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- tosilmetil
- tetrahidrofuran
- metoxi
- alil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicación 1: La sal de fórmula (1) en donde, R¹ es -CH₂-CH=CR⁸R⁸, -CH₂-C(=O)-R⁹ o -CH₂-CH₂-O-R¹⁰, en donde R⁸ y R⁸ cada uno independientemente es H o un grupo hidrocarbonado, teniendo opcionalmente el grupo hidrocarbonado uno o más heteroátomos; R⁹ es OR¹¹, en donde R¹¹ es H o un grupo hidrocarbonado, teniendo opcionalmente el grupo hidrocarbonado uno o más heteroátomos; R¹⁰ es H o un grupo protector de alcohol; R² es H o un grupo protector de alcohol; R³ y R⁴ cada uno independientemente es H, alilo, bencilo o un grupo bencilo sustituido; o R² y uno de R³ y R⁴ juntos forman -C(R¹²)(R¹³)- y el otro R³ y R⁴ es H, alilo, bencilo o un grupo bencilo sustituido, en donde R¹² y R¹³ cada uno independientemente es H o un grupo hidrocarbonado, teniendo opcionalmente e grupo hidrocarbonado uno o más heteroátomos; uno de R⁵ y R⁶ es H y el otro es -CH₂OR¹⁴ o -CH₂SO₂-Ar, o R⁵ y R⁶ tomados juntos forman =CH-SO₂-Ar, donde R¹⁴ es H o un grupo protector de alcohol; y Ar es un grupo arilo; y R⁷ es H, alquilo C₁₋₃ o haloalquilo C₁₋₃; y HX es un ácido.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461948875P | 2014-03-06 | 2014-03-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR099692A1 true AR099692A1 (es) | 2016-08-10 |
Family
ID=54054307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP150100686A AR099692A1 (es) | 2014-03-06 | 2015-03-06 | Derivados cristalinos de (s)-1-((2r,3r,4s,5s)-5-alil-3-metoxi-4-(tosilmetil)tetrahidrofuran-2-il)-3-aminopropan-2-ol |
Country Status (10)
Country | Link |
---|---|
US (1) | US10301274B2 (es) |
EP (1) | EP3114112B1 (es) |
JP (1) | JP6528251B2 (es) |
CN (1) | CN106458947B (es) |
AR (1) | AR099692A1 (es) |
AU (1) | AU2015226806B2 (es) |
CA (1) | CA2940609A1 (es) |
TW (1) | TW201617326A (es) |
UY (1) | UY36023A (es) |
WO (1) | WO2015131286A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10202007520WA (en) | 2016-03-02 | 2020-09-29 | Eisai R&D Man Co Ltd | Eribulin-based antibody-drug conjugates and methods of use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2272840B1 (en) | 1998-06-17 | 2012-08-22 | Eisai R&D Management Co., Ltd. | Intermediate compound for the preparation of halichondrin analogs |
US6462229B1 (en) * | 1998-09-23 | 2002-10-08 | Lonza Ltd. | Process for the preparation of (-)-α-(difluoromethyl)ornithine-monohydrochloride monohydrate |
PL2522663T3 (pl) | 2004-06-03 | 2015-08-31 | Eisai R&D Man Co Ltd | Produkty pośrednie do otrzymywania halichondryny B |
SG189739A1 (en) | 2008-04-04 | 2013-05-31 | Eisai R&D Man Co Ltd | Halichondrin b analogs |
AU2012363334B2 (en) | 2011-12-29 | 2017-02-02 | Alphora Research Inc. | 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl) tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation |
US9278979B2 (en) * | 2012-03-30 | 2016-03-08 | Alphora Research Inc. | Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein |
EP3016957A4 (en) | 2013-07-03 | 2016-11-30 | Alphora Res Inc | SYNTHETIC METHOD FOR THE PRODUCTION OF CYCLIC C1-KETO ANALOGUE OF HALICHONDRIN B AND USEFUL INTERMEDIATE PRODUCTS, INCLUDING INTERMEDIATE PRODUCTS WITH -SO2- (P-TOLYL) GROUPS |
-
2015
- 2015-03-04 TW TW104106860A patent/TW201617326A/zh unknown
- 2015-03-06 JP JP2016555719A patent/JP6528251B2/ja not_active Expired - Fee Related
- 2015-03-06 WO PCT/CA2015/050168 patent/WO2015131286A1/en active Application Filing
- 2015-03-06 US US15/123,310 patent/US10301274B2/en not_active Expired - Fee Related
- 2015-03-06 EP EP15759027.4A patent/EP3114112B1/en active Active
- 2015-03-06 AU AU2015226806A patent/AU2015226806B2/en not_active Ceased
- 2015-03-06 CA CA2940609A patent/CA2940609A1/en not_active Abandoned
- 2015-03-06 CN CN201580011869.9A patent/CN106458947B/zh active Active
- 2015-03-06 UY UY0001036023A patent/UY36023A/es not_active Application Discontinuation
- 2015-03-06 AR ARP150100686A patent/AR099692A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
UY36023A (es) | 2015-10-30 |
AU2015226806A1 (en) | 2016-08-25 |
US10301274B2 (en) | 2019-05-28 |
CA2940609A1 (en) | 2015-09-11 |
EP3114112A4 (en) | 2017-10-04 |
JP2017507159A (ja) | 2017-03-16 |
US20170066735A1 (en) | 2017-03-09 |
EP3114112A1 (en) | 2017-01-11 |
AU2015226806B2 (en) | 2018-11-08 |
CN106458947B (zh) | 2021-01-12 |
JP6528251B2 (ja) | 2019-06-12 |
WO2015131286A1 (en) | 2015-09-11 |
TW201617326A (zh) | 2016-05-16 |
EP3114112B1 (en) | 2021-12-15 |
CN106458947A (zh) | 2017-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR110922A1 (es) | Compuestos inhibidores del vih | |
AR103138A1 (es) | Compuestos de heteroarilo como inhibidores de la irak y usos de los mismos | |
AR104176A1 (es) | Inhibidores de ido (indolamina-2,3-dioxigenasa) | |
AR099995A1 (es) | Piridilamidinas fungicidas | |
AR103969A1 (es) | Inmunomoduladores | |
AR100058A1 (es) | DERIVADOS DE PIRIMIDIN-PIRAZINAS FUSIONADAS MODULADORES DE RORg | |
AR103561A1 (es) | Fenilpiridinas herbicidas | |
AR101189A1 (es) | Heterociclos nitrogenados antiproliferativos y sus métodos de uso | |
AR100886A1 (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
AR091193A1 (es) | HETEROCICLOS DE 5 MIEMBROS QUE CONTIENEN NITROGENO SUSTITUIDO POR CARBOXAMIDA O SULFONAMIDA COMO MODULADORES PARA EL RECEPTOR NUCLEAR HUERFANO RORg | |
AR106258A1 (es) | Compuestos de piridina | |
AR109776A1 (es) | Compuestos de p2x₃ y/o p2x₂/₃ y métodos | |
AR095040A1 (es) | Antagonistas de h3 que contienen un núcleo estructural de fenoxipiperidina | |
AR110351A1 (es) | COMPUESTOS DE HETEROARILO SUSTITUIDOS CON FOSFINÓXIDO ALQUILAMIDA COMO MODULADORES DE RESPUESTAS DE IL-12, IL-23 Y/O IFNa | |
AR100940A1 (es) | Derivados de 1,2,4-triazoles plaguicidas, y sus intermediarios, composiciones y sus procesos relacionados | |
AR101798A1 (es) | Quinolinas herbicidas | |
AR107570A1 (es) | Compuestos químicos | |
AR096827A1 (es) | Uso de piridoncarboxamidas seleccionadas o sus sales como ingredientes activos contra estrés abiótico en plantas | |
AR103024A1 (es) | Piridoncarboxamidas seleccionadas o sus sales como sustancias activas contra estrés abiótico de las plantas | |
AR099692A1 (es) | Derivados cristalinos de (s)-1-((2r,3r,4s,5s)-5-alil-3-metoxi-4-(tosilmetil)tetrahidrofuran-2-il)-3-aminopropan-2-ol | |
AR111474A1 (es) | Compuestos químicos | |
AR104431A1 (es) | Compuestos herbicidas | |
AR102501A1 (es) | Piridilamidinas fungicidas | |
AR102208A1 (es) | Compuestos de isotiazolo tiazina inhibidores de bace1 | |
AR100014A1 (es) | Derivados de 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hidroxiprop-1-il)-4-metoxi-3-(fenilsulfonilmetil)tetrahidrofuran-2-il)acetaldehido y procedimiento para su preparación |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |